HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0450
-0.0030 (-6.25%)
Sep 25, 2026, 2:03 PM AEST
HeraMED Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.15 | 0.29 | 0.36 | 0.61 | 0.32 | 0.12 |
Other Revenue | 0.18 | 0.14 | 0.12 | - | - | - |
| 0.33 | 0.43 | 0.48 | 0.61 | 0.32 | 0.12 | |
Revenue Growth | -24.87% | -10.31% | -20.62% | 88.22% | 170.27% | 132.67% |
Cost of Revenue | 0.38 | 0.38 | - | 0.24 | 0.12 | 0.06 |
Gross Profit | -0.05 | 0.05 | 0.48 | 0.36 | 0.21 | 0.06 |
Selling, General & Admin | 2.46 | 2.51 | 3.91 | 4.22 | 2.56 | 2.47 |
Research & Development | 0.75 | 1.03 | 1.34 | 2.12 | 1.12 | 2.08 |
Operating Expenses | 3.52 | 3.9 | 5.93 | 7.03 | 4.89 | 5.48 |
Operating Income | -3.57 | -3.85 | -5.45 | -6.67 | -4.68 | -5.42 |
Interest Expense | -0 | -0 | -0.05 | -0.01 | -2.18 | -2.19 |
Interest & Investment Income | 0 | 0 | 0.01 | - | - | - |
Currency Exchange Gain (Loss) | -0.26 | -0.05 | - | -0.12 | -0.37 | -0 |
Other Non Operating Income (Expenses) | 0.38 | 0.4 | - | 0.03 | 0.06 | -0.1 |
EBT Excluding Unusual Items | -3.45 | -3.5 | -5.49 | -6.78 | -7.18 | -7.72 |
Asset Writedown | -0.03 | -0.63 | - | - | - | -0.13 |
Pretax Income | -3.47 | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 |
Net Income | -3.47 | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 |
Net Income to Common | -3.47 | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,212 | 1,070 | 532 | 260 | 214 | 175 |
Shares Outstanding (Diluted) | 1,212 | 1,070 | 532 | 260 | 214 | 175 |
Shares Change | 53.78% | 101.27% | 104.14% | 21.65% | 22.61% | 38.84% |
EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.03 | -0.03 | -0.04 |
EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.03 | -0.03 | -0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.21 | -3.66 | -4.81 | -5.71 | -3.77 | -4.47 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.03 |
Gross Margin | -15.34% | 11.69% | 100.00% | 60.05% | 64.24% | 51.24% |
Operating Margin | -1079.22% | -891.10% | -1132.82% | -1100.13% | -1453.02% | -4545.69% |
Profit Margin | -1050.98% | -957.27% | -1140.95% | -1117.60% | -2229.48% | -6588.22% |
Free Cash Flow Margin | -971.80% | -847.42% | -1000.44% | -942.64% | -1171.67% | -3751.19% |
EBITDA | -3.68 | -3.82 | -5.41 | -6.59 | -4.66 | -5.41 |
D&A For EBITDA | -0.11 | 0.02 | 0.04 | 0.08 | 0.02 | 0.01 |
EBIT | -3.57 | -3.85 | -5.45 | -6.67 | -4.68 | -5.42 |